Keyphrases
Quantitative Evaluation
100%
Antitrypsin
100%
Retroviral Transduction
100%
Promoter Elements
100%
Liver-directed Gene Therapy
100%
Long Terminal Repeat
42%
Polymerase II
42%
Hepatocytes
28%
Retrovirus
28%
In Vivo Delivery
28%
Inherited Disease
14%
Gene Expression
14%
MRNA Level
14%
Retroviral Vector
14%
Gene Regulatory Elements
14%
Reporter Gene
14%
Paucity
14%
Titer
14%
Delivery System
14%
Long-term Expression
14%
Proviral DNA
14%
Portal Vein
14%
Moloney murine Leukemia Virus
14%
DNA Data
14%
Quantitative Assay
14%
Rat Hepatocytes
14%
RNA Polymerase II (RNAPII)
14%
In Vivo Transduction
14%
In Vivo Expression
14%
Hepatectomy
14%
Tissue Culture Cells
14%
Inflow Occlusion
14%
Large Subunit
14%
Transduction Methods
14%
In Vivo Rat
14%
Term Analysis
14%
Quantitative PCR Assay
14%
Biochemistry, Genetics and Molecular Biology
Gene Therapy
100%
Quantitative Technique
100%
Promoter Region
100%
Pribnow Box
100%
Hepatocyte
60%
Polymerase
60%
Long Terminal Repeat
60%
Serum (Blood)
40%
Retrovirus
40%
Real-Time Polymerase Chain Reaction
20%
Gene Expression
20%
Genetic Disorder
20%
Retrovirus Vector
20%
Reporter Gene
20%
Regulatory Element
20%
in Vivo Gene Transfer
20%
Titer
20%
RNA Polymerase II
20%
Moloney Murine Leukemia Virus
20%
Tissue Culture Cell
20%
Messenger RNA
20%
Neuroscience
In Vivo
100%
Promoter Region
100%
Long Terminal Repeat
50%
Polymerase
50%
Gene Expression
16%
Cell Culture
16%
Real-Time Polymerase Chain Reaction
16%
Reporter Gene
16%
Aciclovir
16%
Retrovirus Vector
16%
Hepatic Portal Vein
16%
RNA Polymerase II
16%
in Vivo Gene Transfer
16%
Regulator Gene
16%
Messenger RNA
16%
Pharmacology, Toxicology and Pharmaceutical Science
Trypsin Inhibitor
100%
Retrovirus
28%
Genetic Disorder
14%
Cell Culture
14%
Retrovirus Vector
14%
Aciclovir
14%
Moloney Murine Leukemia Virus
14%
RNA Polymerase II
14%
Messenger RNA
14%